Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark

Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.

Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know

In the closing of the recent trading day, Abbott (ABT) stood at $111.50, denoting a +1.35% change from the preceding trading day.

Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval

Seasoned investors typically pay close attention to “stocks with analyst approval,” a sign of potential success and resilience in the ever-volatile equity market landscape. Currently, we are in a p...

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.

Want Decades of Passive Income? 2 Stocks to Buy Now.

Johnson & Johnson and Abbott Laboratories have impressive track records of paying and growing their dividends. Both healthcare leaders have robust businesses and exciting growth opportunities.

3 Stocks to Buy Right Now for the Coming Recession

Inflation came in much hotter than expected in February. Core services inflation, which excludes housing, rose 0.5% from January following a 0.9% increase from December.

3 Resilient Stocks to Protect Your Wealth During a Recession

As the world economy teeters on the verge of instability, three titans have survived many financial storms and emerged stronger than ever from the waves of uncertainty. Here, recognizing these busi...

Abbott (ABT) Stock Slides as Market Rises: Facts to Know Before You Trade

Abbott (ABT) closed at $111.50 in the latest trading session, marking a -1.47% move from the prior day.

Abbott (ABT) Exceeds Market Returns: Some Facts to Consider

In the most recent trading session, Abbott (ABT) closed at $113.16, indicating a +0.64% shift from the previous trading day.

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts oft...

Abbott (ABT) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Medical Devices ETF Hits 52-Week High: Stocks to Watch

Historically viewed as a defensive area, health care also boasts many growth aspects and benefits from advances in technology.

Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note

In the closing of the recent trading day, Abbott (ABT) stood at $120.76, denoting a +0.47% change from the preceding trading day.

General Motors' executive vice president for software and services Mike Abbott to step down

General Motors said on Tuesday that Mike Abbott will step down as executive vice president, software and services, due to health reasons.

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note

In the most recent trading session, Abbott (ABT) closed at $120.19, indicating a -0.64% shift from the previous trading day.


Related Companies

Track Institutional and Insider Activities on ABT

Follow ABBOTT LABORATORIES and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT